Kadil, Youness published the artcileIn silico study of pharmacological treatments against SARS-CoV2 main protease, Recommanded Product: 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, the main research area is in silico pharmacol treatment SARS CoV2 main protease.
The COVID-19 caused by a new type of coronavirus has emerged from China and led to thousands of death globally. Despite the efforts engaged in studying this newly emerged virus and searching for its treatment, the understanding of the COVID-19 drug and target protein interactions still represent a key challenge. Several mols. have demonstrated In-Vitro activity against the SARS-CoV-2 virus and/ or potential clin. benefit in observational and non-randomized studies. Randomized clin. trials of an appropriate size are currently ongoing to establish the efficacy of these therapeutic proposals. Herein, concerning these diverse guidelines and therapeutic suggestions of different approaches to the treatment, this research aims to provide a mol. anal. of the interaction between the principal mols. cited in bibliog. and the active protease site of the virus.
Journal of Pure and Applied Microbiology published new progress about Antiviral agents. 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, Recommanded Product: 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics